[1] 金汉珍,黄德珉,官希吉.实用新生儿学[M].3版.北京:人民卫生出版社,2002:177-179.
[2] Rabinovitch M.Molecular pathogenesis of pulmonary arterial hypertension[J].J Clin Invest,2008,118:2372-2379.
[3] Galiè N,Hoeper MM,Humbert M,et al.Guidelines for the diagnosis and treatment of pulmonary hypertension[J].Euro Heart,2009,30(20):2493-2537.
[4] 薛守斌,王东,刘巍.缺氧诱导因子1与缺氧性肺动脉高压的研究进展[J].医学综述,2013,19(19):3474-3477.
[5] Pan P,Zhang X.Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide syntheses of rats with hypoxia-induced pulmonary hypertension[J].Exp Boil Med(Maywood),2010,235(5):642-648.
[6] He ZH,Dai AG,Zhang XF,et al.Expressions of hypoxia inducible factor-1 and inducible nitric oxide synthesis gene in the development of hypoxia pulmonary hypertension in rats[J].Clin Rehab Tissue Eng Res,2007,11(36):7290-7294.
[7] 蔡彬梅,陈敬国.缺氧性肺动脉高压新生儿血清中HIF1-α、EPO和ET-1变化测定[J].国际医药卫生导报,2013,19(5):605-607.
[8] 王建荣,周英.缺氧性肺动脉高压新生大鼠肺血管重塑与肺血管HIF1-α、ET-1及iNOS的表达相关研究[J].中国当代儿科杂志,2013,15(2):138-144.
[9] Brussel Mans K,Compernoll EV,TJ WAM,et al.Heterozygous,deficiency of hypoxia-inducible factor-2 alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia[J].J Clin Invest,2009,111(10):1519-1527.
[10] Schiodler MB,Hislop AA,Haworth SG.Porcine pulmonary artery and bronchial responses to endothelin-1 and norepinephrine on recovery from hypoxic pulmonary hypertension[J].Pediatr Res,2006,60(1):71-76.
[11] 王姚爱敏,郝亚平.新生儿持续肺动脉高压患儿血浆心房利钠肽、内皮素-1及血管性假血友病因子的变化[J].中国当代儿科杂志,2013,15(9):718-722.
[12] 曹静,王红,李明霞.内皮素-1在缺氧性肺动脉高压新生儿大鼠肺组织中的表达变化及意义[J].中华实用儿科临床杂志,2013,28(20):1561-1565.
[13] Yan LD,Kong LL,Yong ZH,et al.Inhibition of endothelin-1 and hypoxia-induced pulmonary presser responses in the rat by a novel selective endothelia-A receptor antagonist,di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe[J].J Cardiovascular Pharmacol,2010,56(3):246-254.
[14] Yoshiko Y,Satoshi H,Takeshi H,et al.Erythropoietin-responsive sites in normal and malignant human lung tissues[J].Anant Sci Int,2010,85:204-213.
[15] Vaziri ND.Cardiovascular effects of erythropoietin and anemia correction[J].Curr Opin Nephrol Hypertens,2001,10:633-637.
[16] Wang L,Chopp M.Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF[J].J Cereb Blood Flow Metab,2008,28(7):1361-1368.
[17] Lebel M.Antihypertensive and renal protective effects of Renin-Angiotensin system blockade in uremic rats treated with erythropoietin[J].Am J Hypertens,2006,19:1286-1292.
[18] Cook KM,Figg WD.Angiogenesis' inhibitors:Current strategies and future prospects[J].Ca Cancer J Clin,2010,60(4):222-243.
[19] Bletsa A,Virtej A,Berggreen E.Vascular endothelial growth actors and receptors are up-regulated during development of apical periodontitis[J].J Endod,2012,38:628-635.
[20] Ferrara N.History of discovery:vascular endothelial growth factor[J].Arterioscler Thromb Vasc Biol,2009,29(1):22-24.
[21] Saini Y,Harkema R,LaPres JJ,et al.HIF-1α is essential for normal intrauterine differentiation of alveolar epithelium and surfactant production in the newborn lung of mice[J].J Biol Chem,2008,283(48):33650-33657.
[22] Watts KD,McColley SA.Elevated vascular endothelial growth factor is correlated with elevated erythropoietin in stable,young cystic fibrosis patients[J].Pediatr Pulmonology,2011,46(7):683-687.
[23] Abman SH.Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn[J].Neonatology,2007,91(4):283-290.
[24] Schad JF,Mehzer KR,Hicks MR,et al.Cyclic strain up-regulates VEGF and attenuates proliferation of vascular smooth muscle cells[J].Vasc CelI,2011,3:21-30.